Back to News
Market Impact: 0.35
OSR Health, Inc. Delisted from Nasdaq Following October 23, 2026 Panel Decision
Source: Nasdaq
Regulation & LegislationCompany FundamentalsIPOs & SPACs
On October 23, 2026, OSR Health, Inc. (which files as Bellevue Life Sciences Acquisition Corp.) said the Nasdaq Hearings Panel denied its request for continued listing and determined to delist its securities. The article provides no further details on timing, the reason for delisting, or any market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.55
Ticker Sentiment
OSRH-0.85
More News
- What investors need to know about Alphabet's stock-busting earnings report
- Our next steps for Alphabet stock after earnings disappoint at nearly every turn
- SK Hynix says the memory-chip shortage will last until 2030—and more than half its production is booked for the next two years
- China’s tech darlings are losing their shine. Here’s what’s behind the sell-off
- GE Vernova shares slip despite a beat-and-raise. What the sellers are getting wrong
- Microsoft’s strong quarter backs up its stock rebound. Here's our new price target